Ventavis - Newsfeeds

Cold hands? Don't blame it on the weather: How icy fingers could be a ...: In severe cases, iloprost may be offered; this has similar properties to the natural hormone prostacyclin, which opens up the blood vessels and prevents the blood flow becoming sluggish. 'Because of the side-effects, we reserve it for the severe ...
Portopulmonary Hypertension May Be Treated By A Combination Therapy Of ...: He was treated with sequential, then combination, therapy of the vasodilators Iloprost, Sildenafil, and Bosentan. His condition improved dramatically, with his mPAP falling from 70 to 32mmHg. He underwent liver transplantation, and continued on the ...
Cardiovascular disease gets funded treatment: These are sildenafil, bosentan and iloprost. PHARMAC’s medical director Dr Peter Moodie says bringing treatments for PAH within the Pharmaceutical Schedule will give more clarity to doctors over what is funded. Access to the treatments will be ...
Clinical trial: Iloprost's effects on pulmonary arterial hypertension: This is a study to compare the effects of a single dose of a medication called iloprost (given with an experimental disc) to a placebo on the exercise capability of patients with pulmonary arterial hypertension (PAH). This national study is currently ...
Diagnostic tools and innovative therapies improve patient prognosis: Iloprost did not have a significant effect on participants who continued to smoke throughout the trial. "These promising findings show that oral iloprost has the potential to help prevent lung cancer and improve endobronchial dysplasia in former ...
Drug heals lung damage in ex-smokers: Iloprost, a drug routinely used to treat pulmonary hypertension -- high blood pressure in the lungs -- can heal the lungs of ex-smokers, but provides no benefit to those who continue to smoke, Colorado researchers reported today at a San Francisco ...
Improving Smoking-Caused Lung Damage In Former Smokers: Iloprost, a drug used regularly to treat high blood pressure in the lungs, significantly improves lung damage in former smokers, according to results of a multicenter Phase II clinical trial led by the University of Colorado Cancer Center. The study ...
Actelion To Start Late Stage Trial With PGI2 By End-2009: Actelion generates the bulk of its revenue with Tracleer, a pill against PAH and also offers the drug Ventavis, which PAH patients inhale. In 2008, Tracleer generated sales of CHF1.29 billion and Ventavis CHF94.6 million. Actelion shares have lost 4 ...
Germany May Require Doctors to Review Prescriptions (Update2): The Federal Joint Committee called for a second doctor's review on prescriptions for Actelion Ltd.'s Tracleer and Ventavis and Pfizer Inc.'s Revatio and Thelin today in a statement released prior to a press conference in Berlin. The drugs treat ...

Collins Stewart Initiates Coverage on United Therapeutics (UTHR) with ...: They believe both drugs have competitive advantages leading to favorable uptake, with Adcirca likely cannibalizing Pfizer s Revatio, and Tyvaso likely replacing Actelion's Ventavis and potentially used in less severe Remodulin IV/SQ patients." United ...
United Therapeutics Corporation Q4 2008 Earnings Call Transcript: So we think that all across the board patients on Ventavis are going to asking their physicians to switch to Treprostinil and forget some data and support that. Roger and his team are doing a very innovative multinational, multi-center Ventavis switch ...
Actelion announces Full Year 2008 financial results: In local currencies, Ventavis(R) sales increased by 34 percent. The company believes that the additional patient support programs and improved convenience of the current Ventavis(R) device has led to continued Ventavis(R) sales growth
Actelion announces Half Year financial results 2009: Ventavis® (iloprost) sales amounted to CHF 61.5 million for the first half of 2009 (H1 2008: CHF 37.9 m). This represents an increase of 50 percent in local currencies. Otto Schwarz, President Business Operations, commented: "In the first six months ...
FDA approves United Therapeutics Tyvaso drug: Though, Tyvaso will face a formidable competitor in the more-established Ventavis, another inhaled pulmonary hypertension drug being sold by South San Francisco-based Actelion Pharmaceuticals US Inc. that needs to be administered six to nine times a ...
UPDATE 1-Actelion's Tracleer gets US approval for wider use: * U.S. approval for early pulmonary arterial hypertension * New formulation of Ventavis also approved (Adds details, background) ZURICH, Aug 10 (Reuters) - Europe's biggest biotech company Actelion Ltd (ATLN.VX) said on Monday its Tracleer drug had ...
Actelion US Drugs Expansions Good, But Pipeline Remains Key: ... Tracleer, a pill for pulmonary arterial hypertension, to be used in patients with a milder form of the disease, the company said. Tracleer is already approved in this indication in Europe. At the same time, Actelion's inhalable PAH treatment Ventavis ...
Ventavis (Iloprost) In Pulmonary Arterial Hypertension Receives US ...: Actelion Ltd (SIX: ATLN) announced today that the US Food and Drug Administration (FDA) has approved a new 20 microgram per milliliter (mcg/ml) formulation of Ventavis® as a therapy for New York Heart Association Class III and IV pulmonary arterial ...

Looking for a Ventavis lawyer in District of Columbia? Get in touch with one of our Ventavis lawyers in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need A Ventavis Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Ventavis Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Ventavis Information

Click to View Our Legal Resources

Looking for a Ventavis lawyer in District of Columbia? Get in touch with one of our Ventavis lawyers in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-062707

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Ventavis Click to select a Legal Issue

Close (x)

Find Legal Help for Your Ventavis Case - Submit Your Information Below

Do you need legal assistance with your Ventavis case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Ventavis Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.